Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Biotechnology (3)
Journal of Exposure Science and Environmental Epidemiology (1)
The ISME Journal (1)
Nature Cell Biology (1)
Nature (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)
News (3)

Subject Check one or more subjects to show results from those subjects only.

Astronomy and planetary science
Cell biology
Diseases
Ecology
Health care

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Melanie Marty Clear advanced filters

Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study

The BabyScreen+ study offered genomic screening to 1,000 newborns in Australia, and showed that the approach is feasible and positively received by families, leading to molecular diagnoses in 1.6% of babies.

Sebastian Lunke
Lilian Downie
Zornitza Stark
ResearchOpen Access09 Oct 2025
Nature Medicine

Volume: 31, P: 4236-4245
Fresh from the biotech pipeline: FDA turmoil overshadows 2025 approvals

Leadership changes, staff cuts and a raft of new policies marked an agency in transition. New drug approvals featured more follow-on products than firsts.

Melanie Senior
News19 Jan 2026
Nature Biotechnology

Volume: 44, P: 169-175
Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next?

After two volatile years, FDA approvals in 2024 settled closer to their 10-year average. Will nominated commissioner Marty Makary shake things up, or maintain a steady ship?

Melanie Senior
News20 Jan 2025
Nature Biotechnology

Volume: 43, P: 159-165
Biotech financing: divide and reset

Today’s uniquely challenging biotech climate may result in a more resilient sector.

Melanie Senior
News16 Jun 2025
Nature Biotechnology

Volume: 43, P: 1028-1034
Spin state and deep interior structure of Mars from InSight radio tracking

Analysis of radio science data from the NASA InSight Mars lander reveals details of the rotation of the planet, which have been used to determine fundamental information about its core, mantle and atmosphere.

Sébastien Le Maistre
Attilio Rivoldini
W. Bruce Banerdt
Research14 Jun 2023
Nature

Volume: 619, P: 733-737
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas

Zajac et al. show that in colorectal cancer, decreased TGF-β signalling promotes apical actomyosin contractility and collective apical budding of invading tumour spheres with inverted polarity that drive metastatic spread.

Olivier Zajac
Joel Raingeaud
Fanny Jaulin
Research05 Feb 2018
Nature Cell Biology

Volume: 20, P: 296-306
Phosphorus deficiencies invoke optimal allocation of exoenzymes by ectomycorrhizas

Justin A. Meeds
J. Marty Kranabetter
Melanie D. Jones
ResearchOpen Access08 Jan 2021
The ISME Journal

Volume: 15, P: 1478-1489
Exposures to FD&C synthetic color additives from over-the-counter medications and vitamins in United States children and pregnant women

Ruwan Thilakaratne
Rosemary Castorina
Asa Bradman
ResearchOpen Access01 Mar 2022
Journal of Exposure Science & Environmental Epidemiology

Volume: 33, P: 787-793